Header

UZH-Logo

Maintenance Infos

G-quadruplexes as potential therapeutic targets for embryonal tumors


Shalaby, Tarek; Fiaschetti, Giulio; Nagasawa, Kazuo; Shin-Ya, Kazuo; Baumgartner, Martin; Grotzer, Michael (2013). G-quadruplexes as potential therapeutic targets for embryonal tumors. Molecules, 18(10):12500-12537.

Abstract

Embryonal tumors include a heterogeneous group of highly malignant neoplasms that primarily affect infants and children and are characterized by a high rate of mortality and treatment-related morbidity, hence improved therapies are clearly needed. G-quadruplexes are special secondary structures adopted in guanine (G)-rich DNA sequences that are often present in biologically important regions, e.g. at the end of telomeres and in the regulatory regions of oncogenes such as MYC. Owing to the significant roles that both telomeres and MYC play in cancer cell biology, G-quadruplexes have been viewed as emerging therapeutic targets in oncology and as tools for novel anticancer drug design. Several compounds that target these structures have shown promising anticancer activity in tumor xenograft models and some of them have entered Phase II clinical trials. In this review we examine approaches to DNA targeted cancer therapy, summarize the recent developments of G-quadruplex ligands as anticancer drugs and speculate on the future direction of such structures as a potential novel therapeutic strategy for embryonal tumors of the nervous system.

Abstract

Embryonal tumors include a heterogeneous group of highly malignant neoplasms that primarily affect infants and children and are characterized by a high rate of mortality and treatment-related morbidity, hence improved therapies are clearly needed. G-quadruplexes are special secondary structures adopted in guanine (G)-rich DNA sequences that are often present in biologically important regions, e.g. at the end of telomeres and in the regulatory regions of oncogenes such as MYC. Owing to the significant roles that both telomeres and MYC play in cancer cell biology, G-quadruplexes have been viewed as emerging therapeutic targets in oncology and as tools for novel anticancer drug design. Several compounds that target these structures have shown promising anticancer activity in tumor xenograft models and some of them have entered Phase II clinical trials. In this review we examine approaches to DNA targeted cancer therapy, summarize the recent developments of G-quadruplex ligands as anticancer drugs and speculate on the future direction of such structures as a potential novel therapeutic strategy for embryonal tumors of the nervous system.

Statistics

Citations

21 citations in Web of Science®
21 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

56 downloads since deposited on 07 Nov 2013
5 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:10 October 2013
Deposited On:07 Nov 2013 11:31
Last Modified:20 Aug 2016 07:55
Publisher:MDPI Publishing
ISSN:1420-3049
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.3390/molecules181012500
PubMed ID:24152672

Download

Download PDF  'G-quadruplexes as potential therapeutic targets for embryonal tumors'.
Preview
Content: Published Version
Language: English
Filetype: PDF
Size: 299kB
View at publisher